Show simple item record

dc.contributor.authorGarbe, Julia
dc.contributor.authorWesche, Andrea
dc.contributor.authorBunk, Boyke
dc.contributor.authorKazmierczak, Marlon
dc.contributor.authorSelezska, Katherina
dc.contributor.authorRohde, Christine
dc.contributor.authorSikorski, Johannes
dc.contributor.authorRohde, Manfred
dc.contributor.authorJahn, Dieter
dc.contributor.authorSchobert, Max
dc.date.accessioned2014-10-16T13:31:48Z
dc.date.available2014-10-16T13:31:48Z
dc.date.issued2010
dc.identifier.citationCharacterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions. 2010, 10:301 BMC Microbiol.en
dc.identifier.issn1471-2180
dc.identifier.pmid21110836
dc.identifier.doi10.1186/1471-2180-10-301
dc.identifier.urihttp://hdl.handle.net/10033/332801
dc.description.abstractPseudomonas aeruginosa causes lung infections in patients suffering from the genetic disorder Cystic Fibrosis (CF). Once a chronic lung infection is established, P. aeruginosa cannot be eradicated by antibiotic treatment. Phage therapy is an alternative to treat these chronic P. aeruginosa infections. However, little is known about the factors which influence phage infection of P. aeruginosa under infection conditions and suitable broad host range phages.
dc.language.isoenen
dc.rightsArchived with thanks to BMC microbiologyen
dc.subject.meshBacteriophagesen
dc.subject.meshBiological Therapyen
dc.subject.meshCystic Fibrosisen
dc.subject.meshGenome, Viralen
dc.subject.meshHost Specificityen
dc.subject.meshHumansen
dc.subject.meshLung Diseasesen
dc.subject.meshModels, Biologicalen
dc.subject.meshPseudomonas Infectionsen
dc.subject.meshPseudomonas aeruginosaen
dc.subject.meshSputumen
dc.titleCharacterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.en
dc.typeArticleen
dc.identifier.journalBMC microbiologyen
refterms.dateFOA2018-06-12T23:15:04Z
html.description.abstractPseudomonas aeruginosa causes lung infections in patients suffering from the genetic disorder Cystic Fibrosis (CF). Once a chronic lung infection is established, P. aeruginosa cannot be eradicated by antibiotic treatment. Phage therapy is an alternative to treat these chronic P. aeruginosa infections. However, little is known about the factors which influence phage infection of P. aeruginosa under infection conditions and suitable broad host range phages.


Files in this item

Thumbnail
Name:
garbe et al_final.pdf
Size:
624.0Kb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record